Hypoxia-preconditioned mesenchymal stem cells attenuate peritoneal adhesion through TGF-β inhibition
Article Sidebar
Main Article Content
Abstract
Background
Peritoneal adhesions (PAs) are generally described as fibrous bands between intra-abdominal organs following an abdominal surgical operation. The definitive treatments of PAs are currently ineffective yet. Hypoxia-mesenchymal stem cells (H-MSCs) have a higher capability to survive at the site of injury than normoxia-MSCs (N-MSCs) to repair injured tissue without fibrosis. This study aimed to analyze the effect of H-MSCs in controlling formation of PAs by reducing TGF-β level in a rat model.
Methods
A study of post-test only control group design was conducted, involving eighteen PA rat models weighing 250 ± 25 g that were randomly assigned into 3 groups, comprising control group (C), and groups T1 and T2 receiving H-MSC treatment at doses of 3 x 106 and 1.5 x 106, respectively. To induce H-MSCs, MSCs were incubated in hypoxic conditions at 5% O2 and 37oC for 24 hours. Expression level of TGF-β was analyzed by enzyme-linked immunosorbent assay (ELISA) at 450 nm and adhesion formation was described macroscopically. The Kruskal-Wallis variance analysis was used to analyze significant differences among the groups.
Results
The results of this study showed that H-MSCs in group T1 inhibited TGF-β expression significantly on day 8 (p<0.001) and day 14 (p<0.05). Moreover, there was almost no adhesion apparent following H-MSC administration in group T1.
Conclusions
Based on this study, we conclude that H-MSCs may attenuate PA formation following inhibition of TGF-β expression in the PA rat model.
Article Details
Issue
Section
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The journal allows the authors to hold the copyright without restrictions and allow the authors to retain publishing rights without restrictions.
How to Cite
References
Tabibian N, Swehli E, Boyd A, Umbreen A, Tabibian JH. Abdominal adhesions: a practical review of an often overlooked entity. Ann Med Surg (Lond) 2017;15:9–13. doi: 10.1016/j.amsu.2017.01.021.
Arung W, Meurisse M, Detry O. Pathophysiology and prevention of postoperative peritoneal adhesions. World J Gastroenterol 2011;17:4545–53. doi: 10.3748/wjg.v17.i41.4545.
Wang G, Wu K, Li W, et al. Cross talk between IL‐17 and TGF‐β. Wound Repair Regen 2014;22: 631-9. doi: 10.1111/wrr.12203.
Rocca A, Aprea G, Surfaro G, et al. Prevention and treatment of peritoneal adhesions in patients affected by vascular diseases following surgery: a review of the literature. Open Med (Wars) 2016;11:106–14. doi: 10.1515/med-2016-0021.
Yao S, Tanaka E, Matsui Y, et al. Does laparoscopic adhesiolysis decrease the risk of recurrent symptoms in small bowel obstruction? A propensity score-matched analysis. Surg Endosc 2017;31:5348. https://doi.org/10.1007/s00464-017-5615-9.
Glenn JD, Whartenby KA. Mesenchymal stem cells: emerging. mechanisms of immunomodulation and therapy. World J Stem Cells 2014;6:526–39. doi: 10.4252/wjsc.v6.i5.526.
Maleki M, Ghanbarvand F, Behvarz MR, Ejtemaei M, Ghadirkhomi E. Comparison of mesenchymal stem cell markers in multiple human adult stem cells. Int J Stem Cells 2014;7:118-26. http://dx.doi.org/10.15283/ijsc.2014.7.2.118.
Raoufi MF, Tajik P, Dehghan MM, Eini F, Barin A. Isolation and differentiation of mesenchymal stem cells from bovine umbilical cord blood. Reprod Domest Anim 2011;46:95-9. doi: 10.1111/j.1439-0531.2010.01594.x .
Yustianingsih V, Sumarawati T, Putra A. Hypoxia enhances self-renewal properties and markers of mesenchymal stem cells. Univ Med 2019;38:164-71. doi: 10.18051/UnivMed.2019.v38.156-163.
Salazar‐Noratto GE, Luo G, Denoeud C, et al. Concise review: understanding and leveraging cell metabolism to enhance mesenchymal stem cell transplantation survival in tissue engineering and regenerative medicine applications. Stem Cells 2020;38:22–33. doi: 10.1002/stem.3079.
Lotfinia M, Lak S, Mohammadi Ghahhari N, et al. Hypoxia pre-conditioned embryonic mesenchymal stem cell secretome reduces IL-10 production by peripheral blood mononuclear cells. Iran Biomed J 2017;21:24–31. doi: 10.6091/.21.1.24.
Caja L, Dituri F, Mancarella S, et al. TGF-β and the tissue micro environment : relevance in fibrosis and cancer. Int J Mol Sci 2018;19:1294. https://doi.org/10.3390/ijms19051294 PMid:29701666.
Bobyleva PI, Andreeva ER, Gornostaeva AN, Buravkova LB. Tissue-related hypoxia attenuates proinflammatory effects of allogeneic PBMCs on adipose-derived stromal cells in vitro. Stem Cells Int 2016;2016:4726267. doi: 10.1155/2016/4726267.
Muhar AM, Putra A, Warli SM, Munir D. Hypoxia-mesenchymal stem cells inhibit intra-peritoneal adhesions formation by upregulation of the IL-10 expression. Maced J Med Sci 2019;7:3937‐43. doi: 10.3889/oamjms.2019.713.
Charan J, Kantharia ND. How to calculate sample size in animal studies?. J Pharmacol Pharmacother 2013;4:303-6. doi:10.4103/0976-500X.119726.
Karaca G, Pehlivanli F, Aydin O, et al. The effect of mesenchymal stem cell use on intraabdominal adhesions in a rat model. Ann Surg Treat Res 2018;94:57-62. https://doi.org/10.4174/astr.2018.94.2.57.
Moris D, Chakedis J, Rahnemai-Azar AA, et al. Postoperative abdominal adhesions: clinical significance and advances in prevention and management. J Gastrointest Surg 2017;21:1713–22. https://doi.org/10.1007/s11605-017-3488-9.
Wei G, Chen X, Wang G, et al. Inhibition of cyclooxygenase-2 prevents intra-abdominal adhesions by decreasing activity of peritoneal fibroblasts. Drug Des Devel Ther 2015;9:3083–98. doi: 10.2147/DDDT.S80221.
Wang G, Wu K, Li W, et al. Cross talk between IL‐17 and TGF‐β. Wound Repair Regen 2014;22: 631-9. doi: 10.1111/wrr.12203.
Yang B, Gong C, Qian Z, et al. Prevention of post-surgical abdominal adhesions by a novel biodegradable thermosensitive PECE hydrogel. BMC Biotechnol 2010;10:65. doi:10.1186/1472-6750-10-65.
Wang N, Shao Y, Mei Y, et al. Novel mechanism for mesenchymal stem cells in attenuating peritoneal adhesion: accumulating in the lung and secreting tumor necrosis factor α-stimulating gene-6. Stem Cell Res Ther 2012;3:51. doi: 10.1186/scrt142.
Lv B, Li F, Fang J, et al. Hypoxia inducible factor 1α promotes survival of mesenchymal stem cells under hypoxia. Am J Transl Res 2017;9:1521-9.
Kraemer B, Wallwiener C, Rajab TK, Brochhausen C, Wallwiener M, Rothmund R. Standardised models for inducing experimental peritoneal adhesions in female rats. Biomed Res Int 2014:435056. doi: 10.1155/2014/435056.
Wang N, Li Q, Zhang L, et al. Mesenchymal stem cells attenuate peritoneal injury through secretion of TSG-6. PLoS One 2012;7:e43768. doi:10.1371/journal.pone.0043768.
Desai VD, Hsia HC, Schwarzbauer JE. Reversible modulation of myofibroblast differentiation in adipose-derived mesenchymal stem cells. PLoS One 2014;9:e86865. doi:10.1371/journal.pone.0086865.
Liu YY, Chiang CH, Hung SC, et al. Hypoxia-preconditioned mesenchymal stem cells ameliorate ischemia/reperfusion-induced lung injury. PLoS One 2017;12:e0187637. doi: 10.1371/journal.pone.0187637.
Branchett WJ, Lloyd CM. Regulatory cytokine function in the respiratory tract. Mucosal Immunol 2019;12:589-600. doi: 10.1038/s41385-019-0158-0.
Pakyari M, Farrokhi A, Maharlooei MK, Ghahary A. Critical role of transforming growth factor beta in different phases of wound healing. Adv Wound Care 2013;2:215–24. doi:10.1089/wound.2012.0406 .
Mutsaers SE, Prele CMA, Pengelly S, Herrick SE. Mesothelial cells and peritoneal homeostasis. Fertil Steril 2016;106:1018-24. doi: 10.1016/j.fertnstert.2016.09.005.
Schlosser K, Wang JP, Dos Santos C, et al. Effects of mesenchymal stem cell treatment on systemic cytokine levels in a phase 1 dose escalation safety trial of septic shock patients. Crit Care Med 2019;47:918–25. doi:10.1097/CCM.0000000000003657.
Filová E, Brynda E, Riedel T, et al. Improved adhesion and differentiation of endothelial cells on surface-attached fibrin structures containing extracellular matrix proteins. J Biomed Mater Res A 2014;102:698-712. doi:10.1002/jbm.a.34733.